In this study, we hypothesized that the modified PD-L1 single-chain antibody (scFv) fused with foreign peptides can not only inhibit PD-L1-mediated T cell suppression but also elicit foreign peptide-specific T cell-mediated antitumor effects without immunoediting of tumor antigens. Here, CD274 is linked to neoplasm.